NEW YORK (GenomeWeb News) - Novartis will use Digilab BioVision's Peptidomics technology to quantitatively characterize peptides in biological samples for biomarker discovery, Digilab announced earlier this month.
 
The agreement renews a deal Novartis and Digilab penned in 2004. Digilab will receive a research payment, milestone payments, and royalties under the new agreement, Digilab said.
 
No further financial details were disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.